Results 21 to 30 of about 1,483,118 (292)

Research on digital twin technology for future 6G

Intelligent and Converged Networks
With advancement in digitalization and simulation technology, digital twin (DT) technology has emerged as a focal point of research in various industries.
Lanlan Li
doaj   +1 more source

Theory overview [PDF]

Proceedings of VIII International Workshop On Charm Physics — PoS(CHARM2016), 2017
14 pages, 4 figures, to appear in the proceedings of CHARM 2016 held in Bologna, Italy; misprints ...
openaire   +3 more sources

The Roundtable Overview ‘The legacy of St. Macarius (Glukharyov) and preparation for missionary service today’ (Moscow, November 18, 2022) [PDF]

Вестник Свято-Филаретовского института, 2023
Mozgov K. A
doaj   +1 more source

Gastrointestinal stromal tumor – An overview

Indian Journal of Medical and Paediatric Oncology, 2020
Gastrointestinal stromal tumors (GISTs) are rare tumors but are most common mesenchymal tumors of the digestive tract. They are commonly seen in the stomach (60%) and small intestine (30%). GISTs are likely derived from the interstitial cells of Cajal or
Anant Ramaswamy, Vikram Chaudhari, Prabhat Bhargava, Manish Bhandare, Rajiv Kumar, Shailesh V Shrikhande, Vikas Ostwal   +6 more
doaj   +1 more source

Research in plant morphoanatomy in the province of Vojvodina in the 20th century [PDF]

Zbornik Matice Srpske za Prirodne Nauke, 2016
In order to understand the diversity of flora and vegetation in a region, the knowledge of the biology of particular plant species is very important.
Luković Jadranka Ž.
doaj   +1 more source

Chinese Herbal Medicine Xingnaojing Injection for Acute Ischemic Stroke: An Overview of Systematic Reviews and Meta-Analyses

Frontiers in Pharmacology, 2021
Background: Xingnaojing injection (XNJ) is the only Chinese herbal injection approved for both intracerebral hemorrhage and ischemic stroke (IS) first-aid on ambulances in China; many systematic reviews (SRs) and meta-analyses (MAs) of XNJ on stroke have
Zi-Yu Tian, Zi-Yu Tian, Zi-Yu Tian, Lu-Da Feng, Lu-Da Feng, Yao Xie, De-Hao Xu, Chong-Yang Zhang, Ling-Bo Kong, Ling-Bo Kong, Rong-Rong An, Li-Fang Ma, Nicola Robinson, Nicola Robinson, Ying Gao, Ying Gao, Jian-Ping Liu   +16 more
doaj   +1 more source

Predicting Chronicity in Children and Adolescents With Newly Diagnosed Immune Thrombocytopenia at the Timepoint of Diagnosis Using Machine Learning‐Based Approaches

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Objectives To identify predictors of chronic ITP (cITP) and to develop a model based on several machine learning (ML) methods to estimate the individual risk of chronicity at the timepoint of diagnosis. Methods We analyzed a longitudinal cohort of 944 children enrolled in the Intercontinental Cooperative immune thrombocytopenia (ITP) Study ...
Severin Kasser, Alice Bizeul, Meera Chitlur, Hugo Donato, Jelena Roganovic, Julia E. Vogt, Thomas Kühne   +6 more
wiley   +1 more source

Botulinum Toxin for Bruxism: An Overview

Toxins
This overview aimed at assessing botulinum toxin type A (BoNT-A)’s effectiveness in managing bruxism compared to a placebo, the absence of treatment, or other interventions in adults.
Manuella Salm Coelho, Júlia Meller Dias de Oliveira, Helena Polmann, Patrícia Pauletto, Cristine Miron Stefani, Lara Catarine De Luca Maciel, Graziela De Luca Canto   +6 more
doaj   +1 more source

Safety and Efficacy of Programmed Cell Death 1 and Programmed Death Ligand-1 Inhibitors in the Treatment of Cancer: An Overview of Systematic Reviews

Frontiers in Immunology, 2022
BackgroundAn influx of systematic reviews (SRs) of programmed cell death 1 (PD-1) and programmed death ligand-1 (PD-L1) checkpoint inhibitors in cancer treatment with or without meta-analysis and with different methodological quality and inconsistent ...
Shun-Long Ou, Jing Luo, Hua Wei, Xiao-Li Qin, Su-Ya Du, Song Wang, Qian Jiang   +6 more
doaj   +1 more source

Organoids in pediatric cancer research

FEBS Letters, EarlyView.
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley   +1 more source